Research Article

In vitro effects of Caffeic Acid Phenethyl Ester (CAPE) on preeclamptic serum-induced endothelial dysfunction

Volume: 65 Number: 3 September 3, 2026
TR EN

In vitro effects of Caffeic Acid Phenethyl Ester (CAPE) on preeclamptic serum-induced endothelial dysfunction

Abstract

Aim: The aim of study was to evaluate the potential protective effects of caffeic acid phenethyl ester (CAPE), one of the major bioactive components of propolis, within an in vitro model of preeclampsia-induced endothelial dysfunction. Materials and Methods: An in vitro endothelial dysfunction was modeled by treating Human Umbilical Vein Endothelial Cells (HUVECs) with serum from preeclamptic women (PE) and endothelial responses were then compared to normotensive pregnancy serum (N) and fetal bovin serum (FBS), which functioned as physiological and standard controls, respectively. To evaluate the effects of CAPE on PE serum-induced endothelial dysfunction, non-cytotoxic concentrations were first determined via the PrestoBlue cell viability assay. Based on these results, 10 and 25 µM CAPE were selected for subsequent experiments. The migratory and angiogenic capabilities of HUVECs were analyzed via wound healing and tube formation experiments to investigate the protective role of CAPE against preeclampsia-associated endothelial impairment. Results: Exposure to PE serum led to a significant reduction in HUVEC viability compared to FBS and N control groups. CAPE treatment at 10 and 25 µM did not significantly alter cell viability in PE serum treated HUVECs. In functional assays, PE serum markedly impaired both endothelial migration and tube formation capacity. CAPE treatment significantly attenuated these impairments, as evidenced by enhanced wound closure and restored angiogenic tube formation in PE-treated HUVECs. Conclusions: Our data demonstrate that CAPE treatment effectively counteracts PE serum-mediated endothelial impairment by promoting cell migration and angiogenic tube formation. These observations highlight the potential role of CAPE in maintaining endothelial integrity during preeclamptic conditions.

Keywords

Supporting Institution

No financial support was received for this study.

Ethical Statement

This study was approved by the Non-Interventional Scientific Research Ethics Committee of Tokat Gaziosmanpaşa University (Approval No: 26-MOBAEK-031).

References

  1. 1. Afrose D, Alfonso-Sánchez S, McClements L. Targeting oxidative stress in preeclampsia. Hypertens Pregnancy. 2025;44(1):2445556.
  2. 2. Riano-Moreno JC, Vargas-Castellanos E, Pedraza A, Díaz-Quiñonez LS, Rangel-Ramos VS. Preeclampsia prediction and diagnosis: a comprehensive historical review from clinical insights to omics perspectives. Front Med (Lausanne). 2025;12:1689745.
  3. 3. Possomato-Vieira JS, Khalil RA. Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia. Adv Pharmacol. 2016;77:361-431.
  4. 4. Parapob N, Luewan S, Kamlungkuea T, Tongsong T. Oxidative Stress in Pathogenesis of Preeclampsia: Mechanistic and Clinical Insights. Antioxidants. 2026;15(3):387.
  5. 5. Wu CF, Huang FD, Sui RF, Sun JX. Preeclampsia serum upregulates CD40/CD40L expression and induces apoptosis in human umbilical cord endothelial cells. Reprod Biol Endocrinol. 2012;10:28.
  6. 6. Brodowski L, Burlakov J, Hass S, von Kaisenberg C, von Versen-Höynck F. Impaired functional capacity of fetal endothelial cells in preeclampsia. PLoS One. 2017;12(5):e0178340.
  7. 7. Wu Y, Sun T, Medina P, Narasimhan P, Stevenson DK, Von Versen-Höynck F, et all.. A Novel Stem Cell Model to Study Preeclampsia Endothelial Dysfunction. Reprod Sci. 2024;31(10):2993-3003.
  8. 8. Martinotti S, Bonsignore G, Ranzato E. Propolis: A Natural Substance with Multifaceted Properties and Activities. Int J Mol Sci. 2025;26(4):1519.

Details

Primary Language

English

Subjects

Clinical Sciences (Other)

Journal Section

Research Article

Publication Date

September 3, 2026

Submission Date

April 14, 2026

Acceptance Date

April 23, 2026

Published in Issue

Year 2026 Volume: 65 Number: 3

APA
Öksel, N., Şanlı, M., & Katar, M. (2026). In vitro effects of Caffeic Acid Phenethyl Ester (CAPE) on preeclamptic serum-induced endothelial dysfunction. Ege Tıp Dergisi, 65(3), 434-440. https://doi.org/10.19161/etd.1929918
AMA
1.Öksel N, Şanlı M, Katar M. In vitro effects of Caffeic Acid Phenethyl Ester (CAPE) on preeclamptic serum-induced endothelial dysfunction. EJM. 2026;65(3):434-440. doi:10.19161/etd.1929918
Chicago
Öksel, Nilgün, Mustafa Şanlı, and Muzaffer Katar. 2026. “In Vitro Effects of Caffeic Acid Phenethyl Ester (CAPE) on Preeclamptic Serum-Induced Endothelial Dysfunction”. Ege Tıp Dergisi 65 (3): 434-40. https://doi.org/10.19161/etd.1929918.
EndNote
Öksel N, Şanlı M, Katar M (September 1, 2026) In vitro effects of Caffeic Acid Phenethyl Ester (CAPE) on preeclamptic serum-induced endothelial dysfunction. Ege Tıp Dergisi 65 3 434–440.
IEEE
[1]N. Öksel, M. Şanlı, and M. Katar, “In vitro effects of Caffeic Acid Phenethyl Ester (CAPE) on preeclamptic serum-induced endothelial dysfunction”, EJM, vol. 65, no. 3, pp. 434–440, Sept. 2026, doi: 10.19161/etd.1929918.
ISNAD
Öksel, Nilgün - Şanlı, Mustafa - Katar, Muzaffer. “In Vitro Effects of Caffeic Acid Phenethyl Ester (CAPE) on Preeclamptic Serum-Induced Endothelial Dysfunction”. Ege Tıp Dergisi 65/3 (September 1, 2026): 434-440. https://doi.org/10.19161/etd.1929918.
JAMA
1.Öksel N, Şanlı M, Katar M. In vitro effects of Caffeic Acid Phenethyl Ester (CAPE) on preeclamptic serum-induced endothelial dysfunction. EJM. 2026;65:434–440.
MLA
Öksel, Nilgün, et al. “In Vitro Effects of Caffeic Acid Phenethyl Ester (CAPE) on Preeclamptic Serum-Induced Endothelial Dysfunction”. Ege Tıp Dergisi, vol. 65, no. 3, Sept. 2026, pp. 434-40, doi:10.19161/etd.1929918.
Vancouver
1.Nilgün Öksel, Mustafa Şanlı, Muzaffer Katar. In vitro effects of Caffeic Acid Phenethyl Ester (CAPE) on preeclamptic serum-induced endothelial dysfunction. EJM. 2026 Sep. 1;65(3):434-40. doi:10.19161/etd.1929918

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.